Skip to Content


In the US, Diacomit (stiripentol systemic) is a member of the drug class gamma-aminobutyric acid reuptake inhibitors and is used to treat Dravet Syndrome.

US matches:

Ingredient matches for Diacomit


Stiripentol is reported as an ingredient of Diacomit in the following countries:

  • Belgium
  • Canada
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Norway
  • Poland
  • Romania
  • Sweden

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.